Androgen receptor action in hormone‐dependent and recurrent prostate cancer
- 17 April 2006
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 99 (2) , 362-372
Abstract
The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite androgen ablation therapy is less certain. Most of these tumors express prostate specific antigen (PSA), an androgen‐regulated gene; moreover, AR is generally highly expressed in recurrent prostate cancer. We propose that AR continues to play a role in many of these tumors and that it is not only the levels of AR, ligands, and co‐regulators, but also the changes in cell signaling that induce AR action in recurrent prostate cancer. These pathways are, therefore, potential therapeutic targets. J. Cell. Biochem. 99: 362–372, 2006.Keywords
This publication has 43 references indexed in Scilit:
- The androgen receptor and signal‐transduction pathways in hormone‐refractory prostate cancer. Part 2: androgen‐receptor cofactors and bypass pathwaysBJU International, 2005
- Signal transduction in prostate cancer progressionClinical Science, 2005
- SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling PathwaysJournal of Biological Chemistry, 2004
- Tyrosine-317 of p52Shc mediates androgen-stimulated proliferation signals in human prostate cancer cellsOncogene, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Ras signaling in prostate cancer progressionJournal of Cellular Biochemistry, 2003
- Role of the Steroid Receptor Coactivator SRC-3 in Cell GrowthMolecular and Cellular Biology, 2003
- ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cellsOncogene, 2003
- A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer GrowthJournal of Biological Chemistry, 2002
- Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate CancerJournal of Biological Chemistry, 2001